Tri Locum Partners »

Insmed shares owned by Tri Locum Partners

Quarter-by-quarter ownership of Insmed (INSM) shares owned by Tri Locum Partners from 13F filings

Historical chart of Tri Locum Partners investment in Insmed

Tip: Access up to 7 years of quarterly data

All positions including Insmed held by Tri Locum Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Insmed by Tri Locum Partners

Quarter filed Position value Share count Share price at filing
2024-06-30 $21M 317k 67.00

More positions owned by Tri Locum Partners

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Argenx Se Sponsored Adr (ARGX)
Ascendis Pharma A/s Sponsored Adr (ASND)
Amgen (AMGN)
Natera (NTRA)
Axsome Therapeutics (AXSM)
Insmed Com Par $.01 (INSM)
Merus N V (MRUS)
Regeneron Pharmaceuticals (REGN)
Madrigal Pharmaceuticals (MDGL)
Inspire Med Sys (INSP)
Avadel Pharmaceuticals Sponsored Adr
Pfizer (PFE)
United Therapeutics Corporation (UTHR)
Legend Biotech Corp Sponsored Ads (LEGN)

View all positions for Tri Locum Partners

Top funds holding Insmed

Vanguard Group
BlackRock
T. Rowe Price Associates
FMR
State Street Corporation
Geode Capital Management
Baker Bros. Advisors
Darwin Global Management
William Blair Investment Management
Jpmorgan Chase & Co
Macquarie Group
Ameriprise Financial
Franklin Resources
Suvretta Capital Management
Alliancebernstein

View all funds holding Insmed